Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy

por Lazzari, Chiara, Gregorc, Vanesa, Santarpia, Mariacarmela
Publicado en J Thorac Dis (2019)

Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example

por Corti, Angelo, Curnis, Flavio, Rossoni, Gilda, Marcucci, Fabrizio, Gregorc, Vanesa
Publicado 2013

Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer

por Gregorc, Vanesa, Lazzari, Chiara, Karachaliou, Niki, Rosell, Rafael, Santarpia, Mariacarmela
Publicado en Transl Lung Cancer Res (2018)

Mechanisms of resistance to osimertinib

por Lazzari, Chiara, Gregorc, Vanesa, Karachaliou, Niki, Rosell, Rafael, Santarpia, Mariacarmela
Publicado en J Thorac Dis (2020)

Temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer

por Lazzari, Chiara, Gregorc, Vanesa, Bulotta, Alessandra, Dottore, Alessia, Altavilla, Giuseppe, Santarpia, Mariacarmela
Publicado en Transl Lung Cancer Res (2018)

Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer

por Lazzari, Chiara, Gregorc, Vanesa, Cangi, Maria Giulia, Giovannetti, Elisa, Bulotta, Alessandra, Santarpia, Mariacarmela
Publicado en J Thorac Dis (2018)

Targeted Therapies in Early Stage NSCLC: Hype or Hope?

por Friedlaender, Alex, Addeo, Alfredo, Russo, Alessandro, Gregorc, Vanesa, Cortinovis, Diego, Rolfo, Christian D.
Publicado en Int J Mol Sci (2020)

Lung cancer screening: who pays? Who receives? The European perspectives

por Novellis, Pierluigi, Cominesi, Silvia Raimondi, Rossetti, Francesca, Mondoni, Michele, Gregorc, Vanesa, Veronesi, Giulia
Publicado en Transl Lung Cancer Res (2021)

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

por Giovannini, Monica, Gregorc, Vanesa, Belli, Carmen, Roca, Elisa, Lazzari, Chiara, Viganò, Maria Grazia, Serafico, Anna, Villa, Eugenio
Publicado 2009

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

por Lazzari, Chiara, Bulotta, Alessandra, Ducceschi, Monika, Viganò, Maria Grazia, Brioschi, Elena, Corti, Francesca, Gianni, Luca, Gregorc, Vanesa
Publicado en Front Med (Lausanne) (2017)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma

por Pontara, Andrea, Paolino, Giovanni, Gregorc, Vanesa, Mercuri, Santo Raffaele, Bulotta, Alessandra, Bearzi, Pietro, Doglioni, Claudio, Rizzo, Nathalie
Publicado en Dermatol Pract Concept (2020)

Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma

por Paolino, Giovanni, Rizzo, Nathalie, Pampena, Riccardo, Bearzi, Pietro, Bulotta, Alessandra, Gregorc, Vanesa, Brianti, Pina, Moliterni, Elisa, Mercuri, Santo Raffaele
Publicado en Dermatol Pract Concept (2020)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?

por Lazzari, Chiara, Karachaliou, Niki, Bulotta, Alessandra, Viganó, Mariagrazia, Mirabile, Aurora, Brioschi, Elena, Santarpia, Mariacarmela, Gianni, Luca, Rosell, Rafael, Gregorc, Vanesa
Publicado en Ther Adv Med Oncol (2018)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer

por Gregorc, Vanesa, Cavina, Raffaele, Novello, Sivia, Grossi, Francesco, Lazzari, Chiara, Capelletto, Enrica, Genova, Carlo, Salini, Giulia, Lambiase, Antonio, Santoro, Armando
Publicado en Oncologist (2018)

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review

por Mirabile, Aurora, Brioschi, Elena, Ducceschi, Monika, Piva, Sheila, Lazzari, Chiara, Bulotta, Alessandra, Viganò, Maria Grazia, Petrella, Giovanna, Gianni, Luca, Gregorc, Vanesa
Publicado en Cancers (Basel) (2019)

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma

por Carretta, Angelo, Bandiera, Alessandro, Muriana, Piergiorgio, Viscardi, Stefano, Ciriaco, Paola, Gajate, Ana Maria Samanes, Arrigoni, Gianluigi, Lazzari, Chiara, Gregorc, Vanesa, Negri, Giampiero
Publicado en Radiol Oncol (2020)

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence

por Mirabile, Aurora, Rivoltini, Licia, Daveri, Elena, Vernieri, Claudio, Mele, Roberto, Porcu, Luca, Lazzari, Chiara, Bulotta, Alessandra, Viganò, Maria Grazia, Cascinu, Stefano, Gregorc, Vanesa
Publicado en Cancers (Basel) (2020)

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities

por Lazzari, Chiara, Bulotta, Alessandra, Cangi, Maria Giulia, Bucci, Gabriele, Pecciarini, Lorenza, Bonfiglio, Silvia, Lorusso, Vincenza, Ippati, Stefania, Arrigoni, Gianluigi, Grassini, Greta, Doglioni, Claudio, Gregorc, Vanesa
Publicado en Diagnostics (Basel) (2020)

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature

por Lazzari, Chiara, Mirabile, Aurora, Bulotta, Alessandra, Viganó, Maria Grazia, Ogliari, Francesca Rita, Ippati, Stefania, Dell’Oca, Italo, Santarpia, Mariacarmela, Lorusso, Vincenza, Reck, Martin, Gregorc, Vanesa
Publicado en Cancers (Basel) (2021)

Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient da...

por Garassino, Marina Chiara, Kawaguchi, Tomoya, Gregorc, Vanesa, Rulli, Eliana, Ando, Masahiko, Marsoni, Silvia, Isa, Shun-ichi, Novello, Silvia, Farina, Gabriella, Barni, Sandro, Torri, Valter, Cinquini, Michela
Publicado en ESMO Open (2018)